Moira focuses on the design and delivery of the current clinical trials and leading the activity to achieve FDA approval for Noctura 400. Moira has a Physics degree and 30 years of experience in innovation and commercialization. Prior to joining PolyPhotonix in 2014, she worked internationally in the chemical industry, MedTech, and healthcare markets.
Current role